Search

Your search keyword '"Tubach, Florence"' showing total 1,096 results

Search Constraints

Start Over You searched for: Author "Tubach, Florence" Remove constraint Author: "Tubach, Florence"
1,096 results on '"Tubach, Florence"'

Search Results

101. Place des études post-AMM dans le suivi des risques du médicament : cahier des charges et méthodologies

104. Lower Rate of Daily Smokers With Symptomatic COVID-19: A Monocentric Self-Report of Smoking Habit Study

105. Lupus érythémateux induits par les inhibiteurs de la pompe à protons : étude de disproportionnalité à partir des bases de données française et mondiale de pharmacovigilance

106. Impact de l’épidémie de COVID-19 lors de la 1ère vague sur les patients de la cohorte PSOBIOTEQ traités pour psoriasis cutané

107. Évolution du maintien des biomédicaments et de l’aprémilast entre 2012 et 2018 chez les patients de la cohorte PsoBioTeq ayant un psoriasis modéré à sévère

108. Stratégies de diminution des posologies de biothérapies en vie réelle : données du registre Psobioteq

109. Phototype et psoriasis : particularités cliniques, choix et réponses thérapeutiques de 1178 patients de la cohorte PsoBioTeq

110. Impact of anti-tumor necrosis factor agents on the risk of colorectal cancer in patients with ulcerative colitis: nationwide French cohort study Short title: Colorectal cancer and anti-TNF in UC

111. Development and real-life use assessment of a self-management smartphone application for patients with inflammatory arthritis. A user-centred step-by-step approach

113. Managing Osteoarthritis Of The Knee

116. Step-down strategy of spacing TNF-blocker injections for established rheumatoid arthritis in remission: results of the multicentre non-inferiority randomised open-label controlled trial (STRASS: Spacing of TNF-blocker injections in Rheumatoid ArthritiS Study)

117. Rationale and design of a randomized clinical trial (Marfan Sartan) of angiotensin II receptor blocker therapy versus placebo in individuals with Marfan syndrome

118. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial

119. Predicting 90-day survival of patients with COVID-19: Survival of Severely Ill COVID (SOSIC) scores

121. Fully automated opportunistic screening of vertebral fractures and osteoporosis on more than 150 000 routine computed tomography scans

123. Cumulative Incidence of SARS-CoV-2 Infection and Associated Risk Factors Among Frontline Health Care Workers in Paris, France: The SEROCOV Prospective Cohort Study

124. Development and real-life use assessment of a self-management smartphone application for patients with inflammatory arthritis. A user-centred step-by-step approach. (Preprint)

126. Marfan Sartan: a randomized, double-blind, placebo-controlled trial

129. Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspective

133. Inappropriate Use of Oral Antithrombotic Combinations in an Outpatient Setting and Associated Risks: A French Nationwide Cohort Study

134. Development and real-life use assessment of a self-management smartphone application for patients with inflammatory arthritis. A user-centred step-by-step approach.

136. Safety and Persistence of Nalmefene Treatment for Alcohol Dependence. Results from Two Post-authorisation Safety Studies

137. Additional file 6 of Vascular access for renal replacement therapy among 459 critically ill patients: a pragmatic analysis of the randomized AKIKI trial

138. Additional file 3 of Vascular access for renal replacement therapy among 459 critically ill patients: a pragmatic analysis of the randomized AKIKI trial

139. Additional file 5 of Vascular access for renal replacement therapy among 459 critically ill patients: a pragmatic analysis of the randomized AKIKI trial

140. Additional file 4 of Vascular access for renal replacement therapy among 459 critically ill patients: a pragmatic analysis of the randomized AKIKI trial

141. Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia

142. Additional file 7 of Vascular access for renal replacement therapy among 459 critically ill patients: a pragmatic analysis of the randomized AKIKI trial

143. Additional file 1 of Vascular access for renal replacement therapy among 459 critically ill patients: a pragmatic analysis of the randomized AKIKI trial

144. Additional file 2 of Vascular access for renal replacement therapy among 459 critically ill patients: a pragmatic analysis of the randomized AKIKI trial

145. Association Between Lack of Blinding and Mortality Results in Critical Care Randomized Controlled Trials

146. Duration of antibiotic treatment using procalcitonin-guided treatment algorithms in older patients: a patient-level meta-analysis from randomized controlled trials

Catalog

Books, media, physical & digital resources